Dermatomyositis: An Update on Diagnosis and Treatment.
Administration, Cutaneous
Administration, Intravenous
Administration, Oral
Antimalarials
/ administration & dosage
Antipruritics
/ administration & dosage
Autoantibodies
/ blood
Biopsy
Delayed Diagnosis
/ prevention & control
Dermatomyositis
/ blood
Drug Therapy, Combination
/ methods
Humans
Immunoglobulins, Intravenous
/ administration & dosage
Immunosuppressive Agents
/ administration & dosage
Muscle, Skeletal
/ immunology
Protective Clothing
Quality of Life
Severity of Illness Index
Skin
/ immunology
Sunlight
/ adverse effects
Sunscreening Agents
/ administration & dosage
Treatment Outcome
Ultraviolet Rays
/ adverse effects
Journal
American journal of clinical dermatology
ISSN: 1179-1888
Titre abrégé: Am J Clin Dermatol
Pays: New Zealand
ID NLM: 100895290
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
26
2
2020
medline:
30
3
2021
entrez:
26
2
2020
Statut:
ppublish
Résumé
Dermatomyositis is a rare inflammatory disease with characteristic cutaneous findings and varying amounts of systemic involvement. Patients may present with skin disease alone, have concomitant muscle disease, or have extracutaneous manifestations such as pulmonary disease or an associated malignancy. Given such diverse presentations, dermatomyositis is both a diagnostic and therapeutic challenge. However, a prompt diagnosis is of utmost importance to institute adequate therapy and screen patients for an associated malignancy. Dermatologists should play a crucial role in the diagnosis and management of patients with dermatomyositis as cutaneous disease tends to be chronic, negatively impact quality of life, and be more recalcitrant to therapy. In this review, we discuss diagnosis, with a focus on myositis-specific antibodies and their associated phenotypes. We also review therapies available for this often refractory skin disease.
Identifiants
pubmed: 32096127
doi: 10.1007/s40257-020-00502-6
pii: 10.1007/s40257-020-00502-6
doi:
Substances chimiques
Antimalarials
0
Antipruritics
0
Autoantibodies
0
Immunoglobulins, Intravenous
0
Immunosuppressive Agents
0
Sunscreening Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM